Supply of Topical Anti-Inflammatory and Anesthetic Medication

The contract entails the supply and delivery of two units of HYDROCORTISONE ACETATE AND PRAMOXINE HYD, a commercially available topical pharmaceutical formulation used for anti-inflammatory and anesthetic purposes. All units must be manufactured in full compliance with FDA current Good Manufacturing Practices and adhere to the Federal Acquisition Regulation clause 52.212-4, ensuring product quality, safety, and regulatory validity. Full traceability of each unit through the supply chain is mandatory, requiring precise documentation from raw material sourcing through final delivery. The procurement is structured as a subcontract under the Defense Logistics Agency, which operates under the Department of Defense, and is classified under NAICS code 325412 for pharmaceutical preparation manufacturing. The contract was posted on August 5, 2026, and performance is expected to meet exacting federal standards without any set-aside provisions. Delivery and compliance obligations are tracked under the DLA contract reference SPE2DP26F8795.